Moriarty John B — SEC Form 4 filings
SEC reporting owner CIK 1564621. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-22.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-01-23 to 2026-06-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 4,619 shares, $252,765 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 2,374 shares @ $72.23 ($171,474) in Avidity Biosciences, Inc., filed 2026-01-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Avidity Biosciences, Inc. (RNAM) | Chief Legal Officer | 6 | — | 2 legs · 4,619 sh · $252,765 | 9 |
| Mirati Therapeutics, Inc. (MRTX) | Chief Legal Officer | 1 | — | — | 3 |
| Kardigan, Inc. (KARD) | Chief Legal Officer | 1 | — | — | 1 |
Form 4 filings — Moriarty John B
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-22 | 4 | Kardigan, Inc. (KARD) | Grant/award (A): 47,784 @ $0 | EDGAR |
| 2026-02-27 | 4 | Avidity Biosciences, Inc. (RNAM) | Disposition to issuer (D): 92,054 · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 160,000 (derivative) | EDGAR |
| 2026-01-09 | 4 | Avidity Biosciences, Inc. (RNA) | Sale (S): 2,374 @ $72.23 | EDGAR |
| 2025-12-19 | 4 | Avidity Biosciences, Inc. (RNA) | Grant/award (A): 56,000 @ $0 · Tax withholding (F): 26,824 @ $71.87 | EDGAR |
| 2025-08-05 | 4 | Avidity Biosciences, Inc. (RNA) | Sale (S): 2,245 @ $36.21 | EDGAR |
| 2025-01-08 | 4 | Avidity Biosciences, Inc. (RNA) | Grant/award (A): 25,000 @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-08-05 | 4 | Avidity Biosciences, Inc. (RNA) | Grant/award (A): 25,000 @ $0 · Grant/award (A): 160,000 (derivative) @ $0 | EDGAR |
| 2024-01-23 | 4 | Mirati Therapeutics, Inc. (MRTX) | Disposition to issuer (D): 675 · Disposition to issuer (D): 71,660 · Disposition to issuer (D): 83,525 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1564621 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →